Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 1
2007 2
2010 4
2011 2
2013 1
2014 1
2015 1
2016 2
2017 1
2018 3
2019 2
2021 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, Bagga A. Raina R, et al. Ther Apher Dial. 2019 Feb;23(1):4-21. doi: 10.1111/1744-9987.12763. Epub 2018 Oct 29. Ther Apher Dial. 2019. PMID: 30294946 Review.
Atypical hemolytic uremic syndrome (aHUS), a rare variant of thrombotic microangiopathy, is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal impairment. ...This uncommon disorder is caused by a genetic abnormality
Atypical hemolytic uremic syndrome (aHUS), a rare variant of thrombotic microangiopathy, is characterized by mic
Pathogenesis of Atypical Hemolytic Uremic Syndrome.
Yoshida Y, Kato H, Ikeda Y, Nangaku M. Yoshida Y, et al. J Atheroscler Thromb. 2019 Feb 1;26(2):99-110. doi: 10.5551/jat.RV17026. Epub 2018 Nov 2. J Atheroscler Thromb. 2019. PMID: 30393246 Free PMC article. Review.
Atypical hemolytic uremic syndrome (aHUS) is a type of thrombotic microangiopathy (TMA) defined by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure. aHUS is caused by uncontrolled complement activation in the alternative pa
Atypical hemolytic uremic syndrome (aHUS) is a type of thrombotic microangiopathy (TMA) defined by thrombocytope
Inherited Kidney Complement Diseases.
Lemaire M, Noone D, Lapeyraque AL, Licht C, Frémeaux-Bacchi V. Lemaire M, et al. Clin J Am Soc Nephrol. 2021 Jun;16(6):942-956. doi: 10.2215/CJN.11830720. Epub 2021 Feb 3. Clin J Am Soc Nephrol. 2021. PMID: 33536243 Free PMC article. Review.
Staggering progress was realized toward a better understanding of the genetic underpinnings and pathophysiology of many forms of atypical hemolytic uremic syndrome (aHUS) and C3-dominant glomerulopathies that are driven by complement system abnormal
Staggering progress was realized toward a better understanding of the genetic underpinnings and pathophysiology of many forms of atypical
Atypical hemolytic uremic syndrome.
Loirat C, Frémeaux-Bacchi V. Loirat C, et al. Orphanet J Rare Dis. 2011 Sep 8;6:60. doi: 10.1186/1750-1172-6-60. Orphanet J Rare Dis. 2011. PMID: 21902819 Free PMC article. Review.
Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical hemolytic anemia, thrombocytopenia and renal impairment. ...Investigation of the complement system is required (C3, C4, factor H and factor I plasma concentration, MCP
Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical hemolytic anemia, thrombocytopenia and ren
Atypical hemolytic uremic syndrome.
Kavanagh D, Goodship TH. Kavanagh D, et al. Curr Opin Hematol. 2010 Sep;17(5):432-8. doi: 10.1097/MOH.0b013e32833cae86. Curr Opin Hematol. 2010. PMID: 20613506 Review.
PURPOSE OF REVIEW: The last few years revealed a molecular distinction between thrombotic thrombocytopenic purpura, a disease characterized by a lack of ADAMTS13 activity, and atypical hemolytic uremic syndrome (aHUS), a disease of complement overactiv …
PURPOSE OF REVIEW: The last few years revealed a molecular distinction between thrombotic thrombocytopenic purpura, a disease characterized …
Thrombotic thrombocytopenic purpura.
Lämmle B, Kremer Hovinga JA, Alberio L. Lämmle B, et al. J Thromb Haemost. 2005 Aug;3(8):1663-75. doi: 10.1111/j.1538-7836.2005.01425.x. J Thromb Haemost. 2005. PMID: 16102032 Free article. Review.
This overview summarizes the history of thrombotic thrombocytopenic purpura (TTP) from its initial recognition in 1924 as a most often fatal disease to the discovery in 1997 of ADAMTS-13 deficiency as a major risk factor for acute disease manifestation. The cloning of the …
This overview summarizes the history of thrombotic thrombocytopenic purpura (TTP) from its initial recognition in 1924 as a most often fatal …
De novo thrombotic microangiopathy after kidney transplantation.
Garg N, Rennke HG, Pavlakis M, Zandi-Nejad K. Garg N, et al. Transplant Rev (Orlando). 2018 Jan;32(1):58-68. doi: 10.1016/j.trre.2017.10.001. Epub 2017 Nov 4. Transplant Rev (Orlando). 2018. PMID: 29157988 Review.
Post-transplant TMA is usually classified into two categories: 1) recurrent TMA and 2) de novo TMA. Atypical hemolytic uremic syndrome (aHUS) resulting from dysregulation and over-activation of the alternate complement pathway is a rare disease but the …
Post-transplant TMA is usually classified into two categories: 1) recurrent TMA and 2) de novo TMA. Atypical hemolytic urem
Retinal disease in the C3 glomerulopathies and the risk of impaired vision.
Savige J, Amos L, Ierino F, Mack HG, Symons RC, Hughes P, Nicholls K, Colville D. Savige J, et al. Ophthalmic Genet. 2016 Dec;37(4):369-376. doi: 10.3109/13816810.2015.1101777. Epub 2016 Feb 25. Ophthalmic Genet. 2016. PMID: 26915021 Review.
BACKGROUND: Dense deposit disease and atypical hemolytic uremic syndrome are often caused by Complement Factor H (CFH) mutations. This study describes the retinal abnormalities in dense deposit disease and, for the first time, atypical
BACKGROUND: Dense deposit disease and atypical hemolytic uremic syndrome are often caused by Complement Facto
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.
Ruggenenti P, Noris M, Remuzzi G. Ruggenenti P, et al. Kidney Int. 2001 Sep;60(3):831-46. doi: 10.1046/j.1523-1755.2001.060003831.x. Kidney Int. 2001. PMID: 11532079 Free article. Review.
Depending on whether renal or brain lesions prevail, two pathologically indistinguishable but somehow clinically different entities have been described: the hemolytic uremic syndrome (HUS) and the thrombotic thrombocytopenic purpura (TTP). ...Intrinsic abn
Depending on whether renal or brain lesions prevail, two pathologically indistinguishable but somehow clinically different entities have bee …
Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.
Verhave JC, Wetzels JF, van de Kar NC. Verhave JC, et al. Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv131-41. doi: 10.1093/ndt/gfu235. Nephrol Dial Transplant. 2014. PMID: 25165180 Review.
The haemolytic uraemic syndrome (HUS) is part of a spectrum of thrombotic microangiopathies. ...The analysis of genes that encode for complement regulatory proteins and the development of assays for measuring the activity of ADAMTS13 and the detection of antibodies against …
The haemolytic uraemic syndrome (HUS) is part of a spectrum of thrombotic microangiopathies. ...The analysis of genes that encode for …
18 results